Director, Chairman & CEOCIK 0001638643
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | O'Day Daniel PatrickDirector, Chairman & CEO |  GILDGILEAD SCIENCES, INC.Option exercise · 10b5-1 plan | M | $7.42M 102.6K sh | Nov 6, 2026 traded Nov 4, 2026 | |
O'Day Daniel PatrickDirector, Chairman & CEO |
| GILDGILEAD SCIENCES, INC. Open-market sale · 10b5-1 plan |
| SELL |
| $17.98M 102.6K sh |
| Nov 6, 2026 traded Nov 4, 2026 |
| 1 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Option exercise · 10b5-1 plan | M | $710K 9,810 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 10 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Open-market sale · 10b5-1 plan | SELL | $1.72M 9,810 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 0 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Option exercise · 10b5-1 plan | M | — 9,810 sh | Nov 6, 2026 traded Nov 5, 2026 |
| 7 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Option exercise · 10b5-1 plan | M | — 102.6K sh | Nov 6, 2026 traded Nov 4, 2026 |
| 5 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Option exercise | M | — 8,780 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 11 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Tax withholding | F | $613K 4,230 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Option exercise | M | — 8,780 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 12 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Open-market sale · 10b5-1 plan | SELL | $397K 3,050 sh | Apr 29, 2026 traded Apr 28, 2026 |
| 12 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Open-market sale · 10b5-1 plan | SELL | $895K 6,950 sh | Apr 29, 2026 traded Apr 28, 2026 |
| 27 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Open-market sale · 10b5-1 plan | SELL | $15.61M 115.6K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 0 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Option exercise · 10b5-1 plan | M | — 115.6K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 12 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Option exercise · 10b5-1 plan | M | $7.63M 115.6K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 14 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Open-market sale · 10b5-1 plan | SELL | $1.25M 10.0K sh | Dec 30, 2025 traded Dec 29, 2025 |